Condition
Severe Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Severe Infection clinical trials that are recruiting, at sites in 5 countries (most in France (3), China (2), Croatia (1)). By phase: Phase 4 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Severe Infection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Infectious complications in blood cancer patients treated with bispecific antibodies | — | Madrid, Madrid and 1 other locations | Recruiting | May 27, 2026 |
| N-acetylcysteine for severe infection with liver dysfunction in adults | Phase 4 | Copenhagen | Recruiting | Dec 9, 2025 |
| Continuous infusion vs intermittent dosing of ceftazidime/avibactam in critically ill patients | Phase 4 | Zagreb | Recruiting | Feb 6, 2025 |
| Monitoring severe bacterial infections in hospitalized children | — | Créteil | Recruiting | Feb 15, 2024 |
| Descriptive study of severe infections treated with phage therapy | — | Lyon | Recruiting | Dec 29, 2023 |
| Individualized vancomycin dosing for severe infections | Phase 4 | Changsha, Hunan | Recruiting | Dec 8, 2023 |
| Investigating severe infections in pediatric intensive care units in China | — | Shanghai, Shanghai Municipality | Recruiting | Jun 11, 2021 |
| Observing the safety of phage therapy for serious infections | — | Lyon | Recruiting | Dec 2, 2020 |
All recruiting trials (8)
-
Infectious complications in blood cancer patients treated with bispecific antibodies
This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.
-
N-acetylcysteine for severe infection with liver dysfunction in adults
In adults with acute infection or sepsis and liver dysfunction, this study tests whether giving N-acetylcysteine in a four-hour infusion improves days alive and out of the hospital in the first 14 days.
-
Continuous infusion vs intermittent dosing of ceftazidime/avibactam in critically ill patients
This study tests whether giving ceftazidime/avibactam as a continuous infusion works better than standard intermittent dosing for seriously ill ICU patients with certain resistant infections.
-
Monitoring severe bacterial infections in hospitalized children
This study looks at how common and serious bacterial infections are in children in intensive care to help improve how these infections are treated and prevented.
-
Descriptive study of severe infections treated with phage therapy
This study looks at how well phage therapy works for people with severe infections by gathering information from 250 patients treated at a hospital in Lyon.
-
Individualized vancomycin dosing for severe infections
This study tests if giving personalized doses of vancomycin can help people with severe infections do better than the standard dosing method.
-
Investigating severe infections in pediatric intensive care units in China
This study is trying to gather important information about severe infections in children in intensive care units across China to see how common they are and how well different treatments work.
-
Observing the safety of phage therapy for serious infections
This study is testing the safety of using phage therapy to treat serious infections, especially in people with prosthetic joints, by looking at any side effects that might happen.
Related topics
Quick answers
How many Severe Infection clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (3 trials), China (2 trials), Croatia (1 trial), Spain (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.